-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, the U.
The FDA's "mixed" enhanced vaccination authorization is based on clinical trial data provided by the National Institute of Allergy and Infectious Diseases (NIAID), expert committee recommendations, and FDA's analysis of existing data
The FDA also cited examples of “mixed” vaccination in the statement.
In addition, people who are vaccinated with Moderna or Pfizer/BioNTech's new crown vaccine can receive a single dose of Moderna (dose halved), Pfizer/BioNTech, or Johnson's new crown vaccine as an enhanced vaccination after at least 6 months after completing the two injections
The authorization for Moderna's new crown vaccine allows a single dose of Moderna booster vaccine (dose halved) in people who have completed two doses of vaccination for at least 6 months
The authorization for Johnson & Johnson's new crown vaccine allows a single dose of Johnson & Johnson's booster vaccine to be given to adults over the age of 18 who have completed a single dose of vaccination for at least 2 months
With the concerted efforts of the global biomedical industry, a variety of safe and effective vaccines have been developed at a record speed, providing an important tool for protecting public health
Reference materials:
[1] Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines.